Boosting of cellular and humoral immune responses to HPV16/18 antigens by VGX-3100: A follow-on phase I trial. A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11/Ad3 ...
Cervical cancer is the second cause of death among Peruvian women. In Iquitos, Proyecto Precancer engages key stakeholders to develop interventions that address women's needs and prevent cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback